|
Market Closed -
NSE India S.E.
12:05:08 23/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 2,166.60 INR | -1.45% |
|
-2.70% | +6.46% |
| 09-11 | Glenmark Pharmaceuticals Limited Proposes Dividend for the Year Ended 31 March 2026 | CI |
| 09-07 | Acucort wins trademark protection for Zeqmelit in Ukraine | FW |
| Market Cap | 611B 6.44B 5.75B 5.31B 4.82B 9.01B 9.16B 63.94B 25.31B 320B 24.17B 23.66B 1,010B | P/E 2027 * |
26.4x | P/E 2028 * | 21.9x |
|---|---|---|---|---|---|
| Enterprise Value | 576B 6.06B 5.42B 5B 4.53B 8.48B 8.62B 60.2B 23.83B 302B 22.76B 22.27B 951B | EV / Sales 2027 * |
3.4x | EV / Sales 2028 * | 3.01x |
| Free-Float |
51.04% | Yield 2027 * |
0.18% | Yield 2028 * | 0.19% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| GLENMARK | Delayed | |
Bombay S.E.
| GLENMARK | Delayed |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | -1.45% | ||
| 1 week | -2.70% | ||
| Current month | -7.20% | ||
| 1 month | -10.85% | ||
| 3 months | -1.16% | ||
| 6 months | -5.78% | ||
| Current year | +6.46% |
| 1 week | 2,101.6 |  | 2,269.9 |
| 1 month | 2,101.6 | | 2,441.5 |
| Current year | 1,842 | | 2,537.6 |
| 1 year | 1,792.6 | | 2,537.6 |
| 3 years | 722.1 | | 2,537.6 |
| 5 years | 348.5 | | 2,537.6 |
| 10 years | 161.65 | | 2,537.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 31/12/1999 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 26/05/2025 |
Indrajit Bose
PSD | President | - | 14/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 11/05/2011 | |
| Director/Board Member | 86 | 13/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.45% | -2.70% | +19.12% | +185.12% | 6.44B | |
| -2.54% | +1.31% | +54.27% | +114.96% | 1,135B | |
| -1.42% | +3.23% | +38.56% | +74.44% | 635B | |
| +0.16% | +0.08% | +25.29% | +95.23% | 505B | |
| -0.31% | +3.09% | +44.14% | +64.80% | 378B | |
| -1.34% | -0.47% | +66.04% | +41.00% | 358B | |
| -0.68% | +2.65% | +22.98% | +50.39% | 295B | |
| -1.20% | +3.04% | +2.33% | +22.86% | 266B | |
| -1.79% | +1.57% | +50.56% | +59.08% | 237B | |
| -0.73% | -0.10% | +29.02% | +99.67% | 193B | |
| Average | -1.13% | +1.68% | +35.23% | +80.75% | 401.01B | |
| Weighted average by Cap. | -1.35% | +2.65% | +40.99% | +79.92% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 169B 1.79B 1.59B 1.47B 1.33B 2.5B 2.54B 17.72B 7.02B 88.8B 6.7B 6.56B 280B | 187B 1.97B 1.76B 1.63B 1.48B 2.76B 2.81B 19.59B 7.76B 98.14B 7.41B 7.25B 309B |
| Net income | 23.69B 250M 223M 206M 187M 349M 355M 2.48B 981M 12.41B 937M 917M 39.14B | 28.32B 298M 266M 246M 223M 417M 424M 2.96B 1.17B 14.84B 1.12B 1.1B 46.78B |
| Net Debt | -35.75B -377M -336M -311M -282M -527M -535M -3.74B -1.48B -18.73B -1.41B -1.38B -59.05B | -47.16B -497M -444M -410M -371M -695M -706M -4.93B -1.95B -24.71B -1.86B -1.82B -77.9B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/10/26 | ₹2,166.60 | -1.45% | 892,797 |
| 22/10/26 | ₹2,198.50 | +0.20% | 576,619 |
| 21/10/26 | ₹2,194.10 | -0.73% | 568,717 |
| 19/10/26 | ₹2,210.20 | -0.74% | 285,702 |
| 16/10/26 | ₹2,226.70 | -1.06% | 695,427 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
